Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer

BACKGROUND: We sought to determine the prognostic value of pathologic response to neoadjuvant chemotherapy with concurrent trastuzumab. PATIENTS AND METHODS: Two hundred and twenty-nine women with HER2/neu (HER2)-overexpressing breast cancer were treated with neoadjuvant chemotherapy plus trastuzuma...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Kim, M. M., Allen, P., Gonzalez-Angulo, A. M., Woodward, W. A., Meric-Bernstam, F., Buzdar, A. U., Hunt, K. K., Kuerer, H. M., Litton, J. K., Hortobagyi, G. N., Buchholz, T. A., Mittendorf, E. A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2013
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3718505/
https://ncbi.nlm.nih.gov/pubmed/23562929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt131
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन